Drug information

Download files:
Brand Name
Other Names
FTC / RPV / TAF, emtricitabine / rilpivirine / tenofovir AF, emtricitabine / rilpivirine / tenofovir alafenamide fumarate, emtricitabine / rilpivirine hydrochloride / tenofovir AF, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide, emtricitabine / rilpivirine hydrochloride / tenofovir alafenamide fumarate
Drug Class
Combination Drugs
Non-Nucleoside Reverse Transcriptase Inhibitor (rilpivirine)
Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir alafenamide)
Drug Image(s): (Click to enlarge)
Chemical Image: (Click to enlarge)


Molecular Weight: 247.249

rilpivirine hydrochloride

Molecular Weight: 402.8871

tenofovir alafenamide fumarate

Molecular Weight: 1069.0138

(The drug image[s] shown above is of the brand product only. There may be other available products not shown.)

FDA label informationFDA label information

Several FDA-approved drug labels may be available for emtricitabine / rilpivirine / tenofovir alafenamide. Clinicalinfo provides the following link to the DailyMed drug label solely as an example of the labels available for emtricitabine / rilpivirine / tenofovir alafenamide. Inclusion or absence of a drug label link on the Clinicalinfo site does not imply endorsement or lack thereof by Clinicalinfo. Search DailyMed or Drugs@FDA to access more information on emtricitabine / rilpivirine / tenofovir alafenamide, including additional drug labels and any generic equivalents.